Baxter   4Q Revenues: $3.8 billion (+4%) 4Q Earnings: $494 million (+7%) YTD Revenues: $14.2 billion (+2%) YTD Earnings: $2.3 billion (+5%) Comments: BioScience revenues were $1.7 billion in the quarter, up 7%. U.S. sales were $1.6 billion, up 7%, driven by sales growth for Advate, and Gammagard Liquid, as well as other plasma-based therapeutics. International sales were up 2% to $2.2 billion. Medical Products sales were $2.1 billion, up 2%, driven primarily by gains in peritoneal dialysis p...